Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

NCT04133532 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT04133532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04133532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
Lead sponsor
University Hospital, Motol
Phase
Phase 4
Overall status
Completed
Start date
March 5, 2020
Completion date
February 23, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy